{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:59:48Z","timestamp":1792652388921,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K01-HL133424"],"award-info":[{"award-number":["K01-HL133424"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL132226"],"award-info":[{"award-number":["R01-HL132226"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["F30 HL134283"],"award-info":[{"award-number":["F30 HL134283"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17SDG33700093"],"award-info":[{"award-number":["17SDG33700093"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Delivery of stem cells to the failing heart is a promising therapeutic strategy. However, the improvement in cardiac function in animal studies has not fully translated to humans. To help bridge the gap between species, we investigated the effects of adult human cardiac stem cells (hCSCs) on contractile function of human engineered cardiac tissues (hECTs) as a species-specific model of the human myocardium.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Human induced pluripotent stem cell-derived cardiomyoctes (hCMs) were mixed with Collagen\/Matrigel to fabricate control hECTs, with an experimental group of hCSC-supplemented hECT fabricated using a 9:1 ratio of hCM to hCSC. Functional testing was performed starting on culture day 6, under spontaneous conditions and also during electrical pacing from 0.25 to 1.0\u2009Hz, measurements repeated at days 8 and 10. hECTs were then frozen and processed for gene analysis using a Nanostring assay with a cardiac targeted custom panel.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The hCSC-supplemented hECTs displayed a twofold higher developed force vs. hCM-only controls by day 6, with approximately threefold higher developed stress and maximum rates of contraction and relaxation during pacing at 0.75\u2009Hz. The spontaneous beat rate characteristics were similar between groups, and hCSC supplementation did not adversely impact beat rate variability. The increased contractility persisted through days 8 and 10, albeit with some decrease in the magnitude of the difference of the force by day 10, but with developed stress still significantly higher in hCSC-supplemented hECT; these findings were confirmed with multiple hCSC and hCM cell lines. The force-frequency relationship, while negative for both, control (\u2212\u20090.687\u2009Hz<jats:sup>\u2212\u20091<\/jats:sup>; <jats:italic>p<\/jats:italic>\u2009=\u20090.013 vs. zero) and hCSC-supplemented (\u2212\u20090.233\u2009Hz<jats:sup>\u2212\u20091<\/jats:sup>;<jats:italic>p<\/jats:italic>\u2009=\u20090.067 vs. zero) hECTs, showed a significant rectification in the regression slope in hCSC-supplemented hECT (<jats:italic>p<\/jats:italic>\u2009=\u20090.011 vs. control). Targeted gene exploration (59 genes) identified a total of 14 differentially expressed genes, with increases in the ratios of <jats:italic>MYH7\/MHY6<\/jats:italic>, <jats:italic>MYL2\/MYL7<\/jats:italic>, and <jats:italic>TNNI3\/TNNI1<\/jats:italic> in hCSC-supplemented hECT versus controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>For the first time, hCSC supplementation was shown to significantly improve human cardiac tissue contractility in vitro, without evidence of proarrhythmic effects, and was associated with increased expression of markers of cardiac maturation. These findings provide new insights about adult cardiac stem cells as contributors to functional improvement of human myocardium.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-019-1486-4","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T19:03:28Z","timestamp":1575486208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissues"],"prefix":"10.1186","volume":"10","author":[{"given":"Jack F.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Mayourian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Stillitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadek","family":"Munawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Broughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Agullo-Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9105-8926","authenticated-orcid":false,"given":"Irene C.","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"issue":"10106","key":"1486_CR1","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/S0140-6736(17)31071-1","volume":"390","author":"M Metra","year":"2017","unstructured":"Metra M, Teerlink JR. Heart failure. Lancet. 2017;390(10106):1981\u201395.","journal-title":"Lancet."},{"issue":"1","key":"1486_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12872-018-0815-3","volume":"18","author":"W Lesyuk","year":"2018","unstructured":"Lesyuk W, Kriza C, Kolominsky-Rabas P. Cost-of-illness studies in heart failure: a systematic review 2004-2016. BMC Cardiovasc Disord. 2018;18(1):74.","journal-title":"BMC Cardiovasc Disord"},{"issue":"8","key":"1486_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001699","volume":"11","author":"T Callender","year":"2014","unstructured":"Callender T, Woodward M, Roth G, Farzadfar F, Lemarie JC, Gicquel S, et al. Heart failure care in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med. 2014;11(8):e1001699.","journal-title":"PLoS Med"},{"issue":"7","key":"1486_CR4","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1161\/CIRCRESAHA.117.312486","volume":"122","author":"BA Tompkins","year":"2018","unstructured":"Tompkins BA, Balkan W, Winkler J, Gyongyosi M, Goliasch G, Fernandez-Aviles F, et al. Preclinical studies of stem cell therapy for heart disease. Circ Res. 2018;122(7):1006\u201320.","journal-title":"Circ Res"},{"issue":"8","key":"1486_CR5","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/CIRCRESAHA.115.307676","volume":"118","author":"Peter Paul Zwetsloot","year":"2016","unstructured":"Zwetsloot PP, Vegh AM, Jansen of Lorkeers SJ, van Hout GP, Currie GL, Sena ES, et al. Cardiac stem cell treatment in myocardial infarction: a systematic review and meta-analysis of preclinical studies. Circ Res 2016;118(8):1223\u20131232.","journal-title":"Circulation Research"},{"issue":"11","key":"1486_CR6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41569-018-0013-0","volume":"15","author":"P Menasche","year":"2018","unstructured":"Menasche P. Cell therapy trials for heart regeneration - lessons learned and future directions. Nat Rev Cardiol. 2018;15(11):659\u201371.","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"1486_CR7","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1161\/CIRCRESAHA.117.312311","volume":"122","author":"T Sano","year":"2018","unstructured":"Sano T, Ousaka D, Goto T, Ishigami S, Hirai K, Kasahara S, et al. Impact of cardiac progenitor cells on heart failure and survival in single ventricle congenital heart disease. Circ Res. 2018;122(7):994\u20131005.","journal-title":"Circ Res"},{"issue":"8","key":"1486_CR8","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1161\/CIRCRESAHA.116.304346","volume":"116","author":"M Gyongyosi","year":"2015","unstructured":"Gyongyosi M, Wojakowski W, Lemarchand P, Lunde K, Tendera M, Bartunek J, et al. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res. 2015;116(8):1346\u201360.","journal-title":"Circ Res"},{"issue":"8","key":"1486_CR9","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/ejhf.1412","volume":"21","author":"Christina Paitazoglou","year":"2019","unstructured":"Paitazoglou C, Bergmann MW, Vrtovec B, Chamuleau SAJ, van Klarenbosch B, Wojakowski W, et al. Rationale and design of the European multicentre study on stem cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE). Eur J Heart Fail. 2019;21(8):1032-41.","journal-title":"European Journal of Heart Failure"},{"issue":"2","key":"1486_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/CIRCRESAHA.118.311217","volume":"123","author":"MN Banerjee","year":"2018","unstructured":"Banerjee MN, Bolli R, Hare JM. Clinical studies of cell therapy in cardiovascular medicine: recent developments and future directions. Circ Res. 2018;123(2):266\u201387.","journal-title":"Circ Res"},{"issue":"7","key":"1486_CR11","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.115.307647","volume":"118","author":"XL Tang","year":"2016","unstructured":"Tang XL, Li Q, Rokosh G, Sanganalmath SK, Chen N, Ou Q, et al. Long-term outcome of administration of c-kit(POS) cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, but structural and functional improvement and proliferation of endogenous cells persist for at least one year. Circ Res. 2016;118(7):1091\u2013105.","journal-title":"Circ Res"},{"key":"1486_CR12","doi-asserted-by":"publisher","first-page":"3536854","DOI":"10.1155\/2018\/3536854","volume":"2018","author":"K Dergilev","year":"2018","unstructured":"Dergilev K, Tsokolaeva Z, Makarevich P, Beloglazova I, Zubkova E, Boldyreva M, et al. C-kit cardiac progenitor cell based cell sheet improves vascularization and attenuates cardiac remodeling following myocardial infarction in rats. Biomed Res Int. 2018;2018:3536854.","journal-title":"Biomed Res Int"},{"issue":"6","key":"1486_CR13","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.athoracsur.2017.04.058","volume":"104","author":"B Wehman","year":"2017","unstructured":"Wehman B, Pietris N, Bigham G, Siddiqui O, Mishra R, Li T, et al. Cardiac progenitor cells enhance neonatal right ventricular function after pulmonary artery banding. Ann Thorac Surg. 2017;104(6):2045\u201353.","journal-title":"Ann Thorac Surg"},{"issue":"7500","key":"1486_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature13309","volume":"509","author":"JH van Berlo","year":"2014","unstructured":"van Berlo JH, Kanisicak O, Maillet M, Vagnozzi RJ, Karch J, Lin SC, et al. C-kit+ cells minimally contribute cardiomyocytes to the heart. Nature. 2014;509(7500):337\u201341.","journal-title":"Nature."},{"key":"1486_CR15","doi-asserted-by":"publisher","first-page":"8701","DOI":"10.1038\/ncomms9701","volume":"6","author":"N Sultana","year":"2015","unstructured":"Sultana N, Zhang L, Yan J, Chen J, Cai W, Razzaque S, et al. Resident c-kit(+) cells in the heart are not cardiac stem cells. Nat Commun. 2015;6:8701.","journal-title":"Nat Commun"},{"key":"1486_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.pharmthera.2017.08.004","volume":"181","author":"V Bianconi","year":"2018","unstructured":"Bianconi V, Sahebkar A, Kovanen P, Bagaglia F, Ricciuti B, Calabro P, et al. Endothelial and cardiac progenitor cells for cardiovascular repair: a controversial paradigm in cell therapy. Pharmacol Ther. 2018;181:156\u201368.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"1486_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1161\/CIRCRESAHA.118.313845","volume":"124","author":"D Trac","year":"2019","unstructured":"Trac D, Maxwell JT, Brown ME, Xu C, Davis ME. Aggregation of child cardiac progenitor cells into spheres activates notch signaling and improves treatment of right ventricular heart failure. Circ Res. 2019;124(4):526\u201338.","journal-title":"Circ Res"},{"issue":"27","key":"1486_CR18","doi-asserted-by":"publisher","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","volume":"109","author":"X Lian","year":"2012","unstructured":"Lian X, Hsiao C, Wilson G, Zhu K, Hazeltine LB, Azarin SM, et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci U S A. 2012;109(27):E1848\u201357.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1486_CR19","first-page":"52010","volume":"91","author":"S Bhattacharya","year":"2014","unstructured":"Bhattacharya S, Burridge PW, Kropp EM, Chuppa SL, Kwok WM, Wu JC, et al. High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry. J Vis Exp. 2014;91:52010.","journal-title":"J Vis Exp"},{"issue":"2","key":"1486_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1096\/fj.13-228007","volume":"28","author":"IC Turnbull","year":"2014","unstructured":"Turnbull IC, Karakikes I, Serrao GW, Backeris P, Lee JJ, Xie C, et al. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. FASEB J. 2014;28(2):644\u201354.","journal-title":"FASEB J"},{"issue":"7","key":"1486_CR21","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1177\/0963689718779346","volume":"27","author":"J Lewandowski","year":"2018","unstructured":"Lewandowski J, Rozwadowska N, Kolanowski TJ, Malcher A, Zimna A, Rugowska A, et al. The impact of in vitro cell culture duration on the maturation of human cardiomyocytes derived from induced pluripotent stem cells of myogenic origin. Cell Transplant. 2018;27(7):1047\u201367.","journal-title":"Cell Transplant"},{"issue":"5","key":"1486_CR22","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/stem.1964","volume":"33","author":"M Zhang","year":"2015","unstructured":"Zhang M, Schulte JS, Heinick A, Piccini I, Rao J, Quaranta R, et al. Universal cardiac induction of human pluripotent stem cells in two and three-dimensional formats: implications for in vitro maturation. Stem Cells. 2015;33(5):1456\u201369.","journal-title":"Stem Cells"},{"issue":"4","key":"1486_CR23","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.cell.2018.11.042","volume":"176","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Rafatian N, Feric NT, Cox BJ, Aschar-Sobbi R, Wang EY, et al. A platform for generation of chamber-specific cardiac tissues and disease modeling. Cell. 2019;176(4):913\u201327 e18.","journal-title":"Cell."},{"issue":"1","key":"1486_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/toxsci\/kfx081","volume":"158","author":"I Mannhardt","year":"2017","unstructured":"Mannhardt I, Eder A, Dumotier B, Prondzynski M, Kramer E, Traebert M, et al. Blinded contractility analysis in hiPSC-cardiomyocytes in engineered heart tissue format: comparison with human atrial trabeculae. Toxicol Sci. 2017;158(1):164\u201375.","journal-title":"Toxicol Sci"},{"issue":"10","key":"1486_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026397","volume":"6","author":"S Schaaf","year":"2011","unstructured":"Schaaf S, Shibamiya A, Mewe M, Eder A, Stohr A, Hirt MN, et al. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One. 2011;6(10):e26397.","journal-title":"PLoS One"},{"issue":"7700","key":"1486_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41586-018-0016-3","volume":"556","author":"K Ronaldson-Bouchard","year":"2018","unstructured":"Ronaldson-Bouchard K, Ma SP, Yeager K, Chen T, Song L, Sirabella D, et al. Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature. 2018;556(7700):239\u201343.","journal-title":"Nature."},{"key":"1486_CR27","doi-asserted-by":"crossref","unstructured":"Turnbull IC, Mayourian J, Murphy JF, Stillitano F, Ceholski DK, Costa KD. Cardiac tissue engineering models of inherited and acquired cardiomyopathies. Methods Mol Biol. 2018;1816:145\u201359.","DOI":"10.1007\/978-1-4939-8597-5_11"},{"issue":"9-10","key":"1486_CR28","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1089\/ten.tea.2018.0212","volume":"25","author":"Timothy Chen","year":"2019","unstructured":"Chen T, Vunjak-Novakovic G. Human tissue-engineered model of myocardial ischemia-reperfusion injury. Tissue Eng Part A. 2019;25(9-10):711-24.","journal-title":"Tissue Engineering Part A"},{"issue":"1","key":"1486_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13287-019-1305-y","volume":"10","author":"AO Wong","year":"2019","unstructured":"Wong AO, Wong G, Shen M, Chow MZ, Tse WW, Gurung B, et al. Correlation between frataxin expression and contractility revealed by in vitro Friedreich's ataxia cardiac tissue models engineered from human pluripotent stem cells. Stem Cell Res Ther. 2019;10(1):203.","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"1486_CR30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1161\/CIRCRESAHA.117.310796","volume":"121","author":"J Mayourian","year":"2017","unstructured":"Mayourian J, Cashman TJ, Ceholski DK, Johnson BV, Sachs D, Kaji DA, et al. Experimental and computational insight into human mesenchymal stem cell paracrine signaling and heterocellular coupling effects on cardiac contractility and arrhythmogenicity. Circ Res. 2017;121(4):411\u201323.","journal-title":"Circ Res"},{"issue":"7","key":"1486_CR31","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIRCRESAHA.118.312420","volume":"122","author":"J Mayourian","year":"2018","unstructured":"Mayourian J, Ceholski DK, Gorski PA, Mathiyalagan P, Murphy JF, Salazar SI, et al. Exosomal microRNA-21-5p mediates mesenchymal stem cell paracrine effects on human cardiac tissue contractility. Circ Res. 2018;122(7):933\u201344.","journal-title":"Circ Res"},{"issue":"2","key":"1486_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/cell.2009.0077","volume":"12","author":"E Galende","year":"2010","unstructured":"Galende E, Karakikes I, Edelmann L, Desnick RJ, Kerenyi T, Khoueiry G, et al. Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells. Cell Reprogram. 2010;12(2):117\u201325.","journal-title":"Cell Reprogram"},{"issue":"2","key":"1486_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1161\/CIRCRESAHA.116.310494","volume":"121","author":"MM Monsanto","year":"2017","unstructured":"Monsanto MM, White KS, Kim T, Wang BJ, Fisher K, Ilves K, et al. Concurrent isolation of 3 distinct cardiac stem cell populations from a single human heart biopsy. Circ Res. 2017;121(2):113\u201324.","journal-title":"Circ Res"},{"issue":"7","key":"1486_CR34","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u201382.","journal-title":"Nat Methods"},{"key":"1486_CR35","first-page":"64","volume":"1","author":"AP Pilbrow","year":"2008","unstructured":"Pilbrow AP, Ellmers LJ, Black MA, Moravec CS, Sweet WE, Troughton RW, et al. Genomic selection of reference genes for real-time PCR in human myocardium. BMC Med Genet. 2008;1:64.","journal-title":"BMC Med Genet"},{"key":"1486_CR36","doi-asserted-by":"publisher","first-page":"420747","DOI":"10.1155\/2008\/420747","volume":"2008","author":"T Hruz","year":"2008","unstructured":"Hruz T, Laule O, Szabo G, Wessendorp F, Bleuler S, Oertle L, et al. Genevestigator v3: a reference expression database for the meta-analysis of transcriptomes. Adv Bioinforma. 2008;2008:420747.","journal-title":"Adv Bioinforma"},{"issue":"2","key":"1486_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1161\/CIRCRESAHA.116.304360","volume":"116","author":"WD Gray","year":"2015","unstructured":"Gray WD, French KM, Ghosh-Choudhary S, Maxwell JT, Brown ME, Platt MO, et al. Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circ Res. 2015;116(2):255\u201363.","journal-title":"Circ Res"},{"issue":"1","key":"1486_CR38","doi-asserted-by":"publisher","first-page":"H221","DOI":"10.1152\/ajpheart.00495.2009","volume":"298","author":"GM Fomovsky","year":"2010","unstructured":"Fomovsky GM, Holmes JW. Evolution of scar structure, mechanics, and ventricular function after myocardial infarction in the rat. Am J Physiol Heart Circ Physiol. 2010;298(1):H221\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"1486_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2018.e00642","volume":"4","author":"F van den Akker","year":"2018","unstructured":"van den Akker F, Vrijsen KR, Deddens JC, Buikema JW, Mokry M, van Laake LW, et al. Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles. Heliyon. 2018;4(6):e00642.","journal-title":"Heliyon."},{"issue":"3","key":"1486_CR40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCRESAHA.112.276501","volume":"112","author":"L Lauden","year":"2013","unstructured":"Lauden L, Boukouaci W, Borlado LR, Lopez IP, Sepulveda P, Tamouza R, et al. Allogenicity of human cardiac stem\/progenitor cells orchestrated by programmed death ligand 1. Circ Res. 2013;112(3):451\u201364.","journal-title":"Circ Res"},{"key":"1486_CR41","doi-asserted-by":"publisher","first-page":"36774","DOI":"10.1038\/srep36774","volume":"6","author":"I Chimenti","year":"2016","unstructured":"Chimenti I, Pagano F, Cavarretta E, Angelini F, Peruzzi M, Barretta A, et al. Beta-blockers treatment of cardiac surgery patients enhances isolation and improves phenotype of cardiosphere-derived cells. Sci Rep. 2016;6:36774.","journal-title":"Sci Rep"},{"issue":"7","key":"1486_CR42","doi-asserted-by":"publisher","first-page":"883","DOI":"10.5966\/sctm.2015-0241","volume":"5","author":"U Agarwal","year":"2016","unstructured":"Agarwal U, Smith AW, French KM, Boopathy AV, George A, Trac D, et al. Age-dependent effect of pediatric cardiac progenitor cells after juvenile heart failure. Stem Cells Transl Med. 2016;5(7):883\u201392.","journal-title":"Stem Cells Transl Med"},{"issue":"18","key":"1486_CR43","doi-asserted-by":"publisher","first-page":"9733","DOI":"10.1074\/jbc.M115.687806","volume":"291","author":"L Teng","year":"2016","unstructured":"Teng L, Bennett E, Cai C. Preconditioning c-kit-positive human cardiac stem cells with a nitric oxide donor enhances cell survival through activation of survival signaling pathways. J Biol Chem. 2016;291(18):9733\u201347.","journal-title":"J Biol Chem"},{"issue":"22","key":"1486_CR44","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1016\/j.jacc.2016.09.925","volume":"68","author":"S Kulandavelu","year":"2016","unstructured":"Kulandavelu S, Karantalis V, Fritsch J, Hatzistergos KE, Loescher VY, McCall F, et al. Pim1 kinase overexpression enhances ckit(+) cardiac stem cell cardiac repair following myocardial infarction in swine. J Am Coll Cardiol. 2016;68(22):2454\u201364.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"1486_CR45","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","volume":"131","author":"MR Zile","year":"2015","unstructured":"Zile MR, Baicu CF, Ikonomidis JS, Stroud RE, Nietert PJ, Bradshaw AD, et al. Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin. Circulation. 2015;131(14):1247\u201359.","journal-title":"Circulation."},{"issue":"24","key":"1486_CR46","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1161\/CIRCULATIONAHA.107.751412","volume":"120","author":"HS Chen","year":"2009","unstructured":"Chen HS, Kim C, Mercola M. Electrophysiological challenges of cell-based myocardial repair. Circulation. 2009;120(24):2496\u2013508.","journal-title":"Circulation."},{"issue":"1","key":"1486_CR47","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/s41467-017-01946-x","volume":"8","author":"IY Shadrin","year":"2017","unstructured":"Shadrin IY, Allen BW, Qian Y, Jackman CP, Carlson AL, Juhas ME, et al. Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues. Nat Commun. 2017;8(1):1825.","journal-title":"Nat Commun"},{"issue":"4","key":"1486_CR48","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1203\/PDR.0b013e318199093c","volume":"65","author":"RF Wiegerinck","year":"2009","unstructured":"Wiegerinck RF, Cojoc A, Zeidenweber CM, Ding G, Shen M, Joyner RW, et al. Force frequency relationship of the human ventricle increases during early postnatal development. Pediatr Res. 2009;65(4):414\u20139.","journal-title":"Pediatr Res"},{"issue":"9","key":"1486_CR49","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1172\/JCI119770","volume":"100","author":"BD Lowes","year":"1997","unstructured":"Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, et al. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest. 1997;100(9):2315\u201324.","journal-title":"J Clin Invest"},{"key":"1486_CR50","doi-asserted-by":"crossref","unstructured":"Cyganek L, Tiburcy M, Sekeres K, Gerstenberg K, Bohnenberger H, Lenz C, et al. Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes. JCI Insight. 2018;3(12):e99941.","DOI":"10.1172\/jci.insight.99941"},{"issue":"7","key":"1486_CR51","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00018-012-1131-1","volume":"70","author":"J England","year":"2013","unstructured":"England J, Loughna S. Heavy and light roles: myosin in the morphogenesis of the heart. Cell Mol Life Sci. 2013;70(7):1221\u201339.","journal-title":"Cell Mol Life Sci"},{"key":"1486_CR52","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.matbio.2015.05.006","volume":"47","author":"B Hinz","year":"2015","unstructured":"Hinz B. The extracellular matrix and transforming growth factor-beta1: tale of a strained relationship. Matrix Biol. 2015;47:54\u201365.","journal-title":"Matrix Biol"},{"issue":"3","key":"1486_CR53","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.cardiores.2004.07.017","volume":"64","author":"M Ikeuchi","year":"2004","unstructured":"Ikeuchi M, Tsutsui H, Shiomi T, Matsusaka H, Matsushima S, Wen J, et al. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc Res. 2004;64(3):526\u201335.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"1486_CR54","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1002\/stem.2036","volume":"33","author":"JL Ruan","year":"2015","unstructured":"Ruan JL, Tulloch NL, Saiget M, Paige SL, Razumova MV, Regnier M, et al. Mechanical stress promotes maturation of human myocardium from pluripotent stem cell-derived progenitors. Stem Cells. 2015;33(7):2148\u201357.","journal-title":"Stem Cells"},{"issue":"12","key":"1486_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209162","volume":"13","author":"K Arai","year":"2018","unstructured":"Arai K, Murata D, Verissimo AR, Mukae Y, Itoh M, Nakamura A, et al. Fabrication of scaffold-free tubular cardiac constructs using a bio-3D printer. PLoS One. 2018;13(12):e0209162.","journal-title":"PLoS One"},{"issue":"6452","key":"1486_CR56","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1126\/science.aav9051","volume":"365","author":"A Lee","year":"2019","unstructured":"Lee A, Hudson AR, Shiwarski DJ, Tashman JW, Hinton TJ, Yerneni S, et al. 3D bioprinting of collagen to rebuild components of the human heart. Science. 2019;365(6452):482\u20137.","journal-title":"Science."},{"issue":"16","key":"1486_CR57","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1161\/CIRCULATIONAHA.117.030785","volume":"137","author":"L Gao","year":"2018","unstructured":"Gao L, Gregorich ZR, Zhu W, Mattapally S, Oduk Y, Lou X, et al. Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine. Circulation. 2018;137(16):1712\u201330.","journal-title":"Circulation."}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1486-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-019-1486-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1486-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T02:12:00Z","timestamp":1606961520000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-019-1486-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1486"],"URL":"https:\/\/doi.org\/10.1186\/s13287-019-1486-4","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"5 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"K.D.C. holds equity in NovoHeart Holdings; research conducted in this study could potentially affect the value of NovoHeart. M.A.S. is the Chief Science Officer and Founding member of CardioCreate, Inc., a regenerative medicine company. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"373"}}